Spots Global Cancer Trial Database for stage ii grade 3 follicular lymphoma
Every month we try and update this database with for stage ii grade 3 follicular lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma | NCT00002565 | Lymphoma | bleomycin sulfa... CHOP regimen cisplatin cyclophosphamid... cytarabine doxorubicin hyd... etoposide idarubicin ifosfamide mesna methylprednisol... mitoxantrone hy... prednisone vincristine sul... | 15 Years - | M.D. Anderson Cancer Center | |
| Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma | NCT00553501 | Lymphoma | epratuzumab rituximab | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma | NCT00553501 | Lymphoma | epratuzumab rituximab | 18 Years - | Alliance for Clinical Trials in Oncology | |
| GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma | NCT00893477 | Lymphoma | rituximab sargramostim gene expression... gene rearrangem... polymerase chai... polymorphism an... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma | NCT00004039 | Lymphoma | recombinant int... rituximab cyclophosphamid... doxorubicin hyd... prednisone vincristine sul... | - | Hoag Memorial Hospital Presbyterian | |
| Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma | NCT00004039 | Lymphoma | recombinant int... rituximab cyclophosphamid... doxorubicin hyd... prednisone vincristine sul... | - | Hoag Memorial Hospital Presbyterian | |
| Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma | NCT00004039 | Lymphoma | recombinant int... rituximab cyclophosphamid... doxorubicin hyd... prednisone vincristine sul... | - | Hoag Memorial Hospital Presbyterian | |
| Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma | NCT00553501 | Lymphoma | epratuzumab rituximab | 18 Years - | Alliance for Clinical Trials in Oncology | |
| SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant | NCT00002657 | Lymphoma Multiple Myelom... | bleomycin sulfa... recombinant int... cyclophosphamid... cytarabine doxorubicin hyd... etoposide methotrexate prednisone vincristine sul... conventional su... radiation thera... | 15 Years - | SWOG Cancer Research Network | |
| SWOG-8819 Collecting, Analyzing, and Storing Tissue Samples From Patients With Non-Hodgkin's Lymphoma | NCT00900484 | Lymphoma | biologic sample... immunohistochem... laboratory biom... | 16 Years - | SWOG Cancer Research Network |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
